Beyond its physiological roles, dysregulated DRP1 activity has been implicated in neurodegenerative diseases, aging, and cancer, with emerging evidence highlighting its contribution to tumor metastasis (Rochon et al., 2024). This evidence concerns the gene DNM1L and cancer.